Goldman Sachs Group Inc Night Hawk Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Night Hawk Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 14,394 shares of NHWK stock, worth $2,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,394

Previous 14,175 1.54%

Holding current value

$2,303

Previous $2,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.16 - $0.17 $35 - $37	219 Added 1.54%	14,394 $2,000
Q1 2024 May 15, 2024	SELL	$0.15 - $0.45 $301 - $904	-2,009 Reduced 12.41%	14,175 $2,000
Q4 2023 Feb 13, 2024	BUY	$0.26 - $0.51 $354 - $696	1,365 Added 9.21%	16,184 $7,000
Q3 2023 May 14, 2024	SELL	$0.5 - $0.72 $682 - $982	-1,365 Reduced 8.43%	14,819 $7,000
Q3 2023 Nov 14, 2023	SELL	$0.5 - $0.72 $612 - $881	-1,224 Reduced 7.63%	14,819 $7,000
Q2 2023 May 14, 2024	BUY	$0.62 - $0.87 $1,253 - $1,758	2,021 Added 14.41%	16,043 $10,000
Q2 2023 Aug 14, 2023	BUY	$0.62 - $0.87 $1,253 - $1,758	2,021 Added 14.41%	16,043 $10,000
Q1 2023 May 14, 2024	SELL	$0.83 - $1.24 $29 - $44	-36 Reduced 0.26%	14,022 $12,000
Q1 2023 May 11, 2023	SELL	$0.83 - $1.24 $29 - $44	-36 Reduced 0.26%	14,022 $12,000
Q4 2022 May 14, 2024	SELL	$0.77 - $1.62 $1,637 - $3,444	-2,126 Reduced 13.14%	14,058 $11,000
Q4 2022 Feb 13, 2023	BUY	$0.77 - $1.62 $10,824 - $22,773	14,058 New	14,058 $11,000
Q1 2022 May 16, 2022	SELL	$2.1 - $3.54 $118,576 - $199,886	-56,465 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.04 - $6.01 $19,085 - $37,730	6,278 Added 12.51%	56,465 $171,000
Q3 2021 Nov 10, 2021	BUY	$5.9 - $7.44 $296,103 - $373,391	50,187 New	50,187 $299,000

Others Institutions Holding NHWK

# of Institutions

Shares Held

48.5K

Call Options Held

Put Options Held

View Full List

About NightHawk Biosciences, Inc.

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

More about NHWK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Night Hawk Biosciences, Inc. Transaction History